| Milan Stock Exchange: PRL
Pierrel SpA engages in the clinical research of medicinal product candidates. It operates through the following business divisions: Tech-driven Contract Research & Development Organization (TCRDO), Contract Manufacturing, and Pharma. The TCRDO division focuses on the repositioning of existing drugs in new indications. The Contract Manufacturing division deals with the production of specialized pharmaceuticals. The Pharma division develops, registers, and licenses new drugs and medical devices. The company was founded on June 30, 2005 and is headquartered in Capua, Italy.